These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21437649)

  • 1. Genetic analysis in mice identifies cysteamine as a novel partner for artemisinin in the treatment of malaria.
    Min-Oo G; Gros P
    Mamm Genome; 2011 Aug; 22(7-8):486-94. PubMed ID: 21437649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin.
    Min-Oo G; Fortin A; Poulin JF; Gros P
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3262-70. PubMed ID: 20479197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.
    Min-Oo G; Ayi K; Bongfen SE; Tam M; Radovanovic I; Gauthier S; Santiago H; Rothfuchs AG; Roffê E; Sher A; Mullick A; Fortin A; Stevenson MM; Kain KC; Gros P
    Exp Parasitol; 2010 Aug; 125(4):315-24. PubMed ID: 20219464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the research on the targets of anti-malaria actions of artemisinin.
    Yang J; He Y; Li Y; Zhang X; Wong YK; Shen S; Zhong T; Zhang J; Liu Q; Wang J
    Pharmacol Ther; 2020 Dec; 216():107697. PubMed ID: 33035577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus.
    Min-Oo G; Fortin A; Pitari G; Tam M; Stevenson MM; Gros P
    J Exp Med; 2007 Mar; 204(3):511-24. PubMed ID: 17312006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Dihydroartemisinin on
    Xu W; Wang H; Tang T; Ma J; Cui Z; Li L; Guo S; Zhou Y; Jiang T; Li C
    Am J Chin Med; 2019; 47(6):1325-1343. PubMed ID: 31488031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin resistance, some facts and opinions.
    Pantaleo A; Pau MC; Chien HD; Turrini F
    J Infect Dev Ctries; 2015 Jul; 9(6):597-9. PubMed ID: 26142668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite.
    Martin RE; Shafik SH; Richards SN
    Curr Opin Pharmacol; 2018 Oct; 42():71-80. PubMed ID: 30142480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of anti-malarial drugs in eliminating malaria.
    White NJ
    Malar J; 2008 Dec; 7 Suppl 1(Suppl 1):S8. PubMed ID: 19091042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
    Pongtavornpinyo W; Yeung S; Hastings IM; Dondorp AM; Day NP; White NJ
    Malar J; 2008 Nov; 7():229. PubMed ID: 18976503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice.
    Pitari G; Malergue F; Martin F; Philippe JM; Massucci MT; Chabret C; Maras B; Duprè S; Naquet P; Galland F
    FEBS Lett; 2000 Oct; 483(2-3):149-54. PubMed ID: 11042271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New dimensions in the field of antimalarial research against malaria resurgence.
    Narula AK; Azad CS; Nainwal LM
    Eur J Med Chem; 2019 Nov; 181():111353. PubMed ID: 31525705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets.
    Ding XC; Beck HP; Raso G
    Trends Parasitol; 2011 Feb; 27(2):73-81. PubMed ID: 21169061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
    Bayih AG; Folefoc A; Mohon AN; Eagon S; Anderson M; Pillai DR
    Malar J; 2016 Dec; 15(1):579. PubMed ID: 27903279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
    Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
    Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.